Exosome extracellular vesicles as biologic therapy for COVID‐19 are discussed for two areas. The first involves the growing use of mesenchymal stromal cells (MSCs) for the profound clinical cytokine storm and severe pneumonia in COVID‐19 patients. Instead, it is recommended ...
Read More »Exosomes in perspective – a potential surrogate for stem cell therapy
Exosomes as a unique subtype of small extracellular vesicles (sEVs) have attracted increasing interest in recent years in the fields of mesenchymal stromal...
Read More »Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use
Extracellular vesicles (EVs) derived from stem and progenitor cells may have therapeutic effects comparable to their parental cells and are considered promising agents for the treatment of a variety of diseases. To this end, strategies must be designed to successfully ...
Read More »MSC-Derived Exosomes for Cell-Free Therapy
Mesenchymal stem cell transplantation is undergoing extensive evaluation as a cellular therapy in human clinical trials. Because MSCs are easily isolated and amenable to culture expansion in vitro there is a natural desire to test MSCs in many diverse clinical ...
Read More »Exosomes from human colorectal cancer induce a tumor-like behavior
Cancer cells, including colorectal cancer ones (CRC), release high amounts of nanovesicles (exosomes), delivering biochemical messages for paracrine or systemic crosstalk. Mesenchymal stromal cells (MSCs) have been shown to play contradicting roles in tumor progression. Researchers at the Istituto Superiore ...
Read More »Tumour cell-derived exosomes confer mesenchymal stromal cells with the ability to enhance tumour growth
Mesenchymal stromal cells (MSCs) are a major component of the tumour microenvironment. A plethora of elegant studies focusing on tumour-derived MSCs have shown that they, unlike normal MSCs in other tissue, exhibit a strong ability to promote tumour progression. However, ...
Read More »Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity
Here, for the first time, researchers at the Henry Ford Hospital test a novel hypothesis that systemic treatment of stroke with exosomes derived from multipotent mesenchymal stromal cells (MSCs) promote neurovascular remodeling and functional recovery after stroke in rats. Adult ...
Read More »